173 related articles for article (PubMed ID: 37597033)
1. Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer.
Guo Y; Xie X; Tang W; Chen S; Wang M; Fan Y; Lin C; Hu W; Yang J; Xiang J; Jiang K; Wei X; Huang B; Jiang X
Eur Radiol; 2024 Feb; 34(2):899-913. PubMed ID: 37597033
[TBL] [Abstract][Full Text] [Related]
2. Lymph node metastasis prediction and biological pathway associations underlying DCE-MRI deep learning radiomics in invasive breast cancer.
Liu W; Chen W; Xia J; Lu Z; Fu Y; Li Y; Tan Z
BMC Med Imaging; 2024 Apr; 24(1):91. PubMed ID: 38627678
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
Eur Radiol; 2024 Feb; ():. PubMed ID: 38363315
[TBL] [Abstract][Full Text] [Related]
4. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
[TBL] [Abstract][Full Text] [Related]
5. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of MRI Radiomics Models to Differentiate HER2-Zero, -Low, and -Positive Breast Cancer.
Peng Y; Zhang X; Qiu Y; Li B; Yang Z; Huang J; Lin J; Zheng C; Hu L; Shen J
AJR Am J Roentgenol; 2024 Apr; 222(4):e2330603. PubMed ID: 38265001
[No Abstract] [Full Text] [Related]
9. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study.
Gu J; Tong T; He C; Xu M; Yang X; Tian J; Jiang T; Wang K
Eur Radiol; 2022 Mar; 32(3):2099-2109. PubMed ID: 34654965
[TBL] [Abstract][Full Text] [Related]
10. A deep learning radiomics model for preoperative grading in meningioma.
Zhu Y; Man C; Gong L; Dong D; Yu X; Wang S; Fang M; Wang S; Fang X; Chen X; Tian J
Eur J Radiol; 2019 Jul; 116():128-134. PubMed ID: 31153553
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma
Zhu M; Kuang Y; Jiang Z; Liu J; Zhang H; Zhao H; Luo H; Chen Y; Peng Y
Gland Surg; 2024 Apr; 13(4):512-527. PubMed ID: 38720675
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
Sang L; Liu Z; Huang C; Xu J; Wang H
Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
[TBL] [Abstract][Full Text] [Related]
13. Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.
Zhang XF; Wu HY; Liang XW; Chen JL; Li J; Zhang S; Liu Z
BMC Womens Health; 2024 Mar; 24(1):182. PubMed ID: 38504245
[TBL] [Abstract][Full Text] [Related]
14. Prenatal Diagnosis of Placenta Accreta Spectrum Disorders: Deep Learning Radiomics of Pelvic MRI.
Peng L; Yang Z; Liu J; Liu Y; Huang J; Chen J; Su Y; Zhang X; Song T
J Magn Reson Imaging; 2024 Feb; 59(2):496-509. PubMed ID: 37222638
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Discrimination of CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytoma: A Deep Learning-Based Radiomics Model Using MRI.
Gao J; Liu Z; Pan H; Cao X; Kan Y; Wen Z; Chen S; Wen M; Zhang L
J Magn Reson Imaging; 2024 May; 59(5):1655-1664. PubMed ID: 37555723
[TBL] [Abstract][Full Text] [Related]
16. Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study.
Yu Y; Ren W; He Z; Chen Y; Tan Y; Mao L; Ouyang W; Lu N; Ouyang J; Chen K; Li C; Zhang R; Wu Z; Su F; Wang Z; Hu Q; Xie C; Yao H
Breast Cancer Res; 2023 Nov; 25(1):132. PubMed ID: 37915093
[TBL] [Abstract][Full Text] [Related]
17. Deep learning radiomics model based on breast ultrasound video to predict HER2 expression status.
Quan MY; Huang YX; Wang CY; Zhang Q; Chang C; Zhou SC
Front Endocrinol (Lausanne); 2023; 14():1144812. PubMed ID: 37143737
[TBL] [Abstract][Full Text] [Related]
18. Prediction of 5-year progression-free survival in advanced nasopharyngeal carcinoma with pretreatment PET/CT using multi-modality deep learning-based radiomics.
Gu B; Meng M; Bi L; Kim J; Feng DD; Song S
Front Oncol; 2022; 12():899351. PubMed ID: 35965589
[TBL] [Abstract][Full Text] [Related]
19. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
[TBL] [Abstract][Full Text] [Related]
20. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
